Literature DB >> 16255041

Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity.

Damien Loeuille1, Isabelle Chary-Valckenaere, Jacqueline Champigneulle, Anne-Christine Rat, Frédéric Toussaint, Astrid Pinzano-Watrin, Jean Christophe Goebel, Didier Mainard, Alain Blum, Jacques Pourel, Patrick Netter, Pierre Gillet.   

Abstract

OBJECTIVE: To determine the magnetic resonance imaging (MRI), macroscopic, and microscopic characteristics of synovial membrane inflammation, to study the relationship between disease severity and the degree of synovial inflammation on MRI and on macroscopic and microscopic examination, and to look for colocalization of chondral lesions and synovial inflammation.
METHODS: Thirty-nine patients with knee osteoarthritis (OA) were classified into 2 groups according to the severity of cartilage lesions as revealed by chondroscopy. Group 1 (n = 14) had mild cartilage lesion(s) without exposure of subchondral bone. Group 2 (n = 25) had severe cartilage lesion(s) with focal or diffuse exposure of subchondral bone. Synovitis was evaluated on T1-weighted MRI sequences according to the degree of synovial thickening on a 4-point scale (ranging from 0 to 3) in 5 regions of interest. Synovial membrane was macroscopically scored, and biopsies were performed on the 5 preselected sites for histologic scoring.
RESULTS: The mean +/- SD synovial thickening score on MRI was 1.55 +/- 0.90, with no significant difference between groups 1 and 2. Intra- and interobserver reproducibility of the total synovial score was excellent, and interobserver reproducibility of the MRI grade was good. Synovitis was diffuse and associated with chondral lesions only in the medial femorotibial compartment (r = 0.49, P = 0.001). The degree of synovial thickening on MRI correlated with qualitative macroscopic analysis (r(s) = 0.58, P < 0.001) and with microscopic features (synovial lining cells [r(s) = 0.23, P < 0.007], surface fibrin deposition [r(s) = 0.12, P < 0.01], fibrosis [r(s) = 0.31, P < 0.006], edema [r(s) = 0.17, P = 0.07], congestion [r(s) = 0.30, P < 0.005], and infiltration [r(s) = 0.46, P < 0.0001]). Fibrin and infiltration parameters were more severe in end-stage disease (P = 0.009 and P = 0.02, respectively).
CONCLUSION: Synovitis may be present from the onset of OA and may be evaluated on MRI. MRI evaluation of synovitis could be used to classify OA patients in clinical trials and could help to identify those who could benefit from synovium-targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255041     DOI: 10.1002/art.21373

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  89 in total

Review 1.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Authors:  Jérémie Sellam; Francis Berenbaum
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

2.  Synovial chemokine expression and relationship with knee symptoms in patients with meniscal tears.

Authors:  A Nair; J Gan; C Bush-Joseph; N Verma; M W Tetreault; K Saha; A Margulis; L Fogg; C R Scanzello
Journal:  Osteoarthritis Cartilage       Date:  2015-02-24       Impact factor: 6.576

3.  Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study.

Authors:  Ali Guermazi; Frank W Roemer; Daichi Hayashi; Michel D Crema; Jingbo Niu; Yuqing Zhang; Monica D Marra; Avinash Katur; John A Lynch; George Y El-Khoury; Kristin Baker; Laura B Hughes; Michael C Nevitt; David T Felson
Journal:  Ann Rheum Dis       Date:  2010-12-27       Impact factor: 19.103

4.  Serum and synovial fluid C-reactive protein level variations in dogs with degenerative joint disease and their relationships with physiological parameters.

Authors:  S Boal; L Miguel Carreira
Journal:  Vet Res Commun       Date:  2015-07-16       Impact factor: 2.459

Review 5.  [Inflammation and osteoarthritis-related pain].

Authors:  T A Nees; N Rosshirt; T Reiner; M Schiltenwolf; B Moradi
Journal:  Schmerz       Date:  2019-02       Impact factor: 1.107

6.  The role of synovitis in osteoarthritis.

Authors:  Claire Y J Wenham; Philip G Conaghan
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 7.  MRI-based semiquantitative scoring of joint pathology in osteoarthritis.

Authors:  Ali Guermazi; Frank W Roemer; Ida K Haugen; Michel D Crema; Daichi Hayashi
Journal:  Nat Rev Rheumatol       Date:  2013-01-15       Impact factor: 20.543

8.  Synovitis in knee osteoarthritis: a precursor of disease?

Authors:  I Atukorala; C K Kwoh; A Guermazi; F W Roemer; R M Boudreau; M J Hannon; D J Hunter
Journal:  Ann Rheum Dis       Date:  2014-12-08       Impact factor: 19.103

9.  Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease.

Authors:  Marla J Steinbeck; Leon J Nesti; Peter F Sharkey; Javad Parvizi
Journal:  J Orthop Res       Date:  2007-09       Impact factor: 3.494

10.  Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.

Authors:  F Bellucci; P Cucchi; C Catalani; S Giuliani; S Meini; C A Maggi
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.